Deltex Net Income From Continuing Ops vs Ebitda Analysis

DEMG Stock

0.08 0.00 0.00%

Deltex Medical financial indicator trend analysis is much more than just examining Deltex Medical Group latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Deltex Medical Group is a good investment. Please check the relationship between Deltex Medical Net Income From Continuing Ops and its Ebitda accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Deltex Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Income From Continuing Ops vs Ebitda

Net Income From Continuing Ops vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Deltex Medical Group Net Income From Continuing Ops account and Ebitda. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Deltex Medical's Net Income From Continuing Ops and Ebitda is 0.98. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Ebitda in the same time period over historical financial statements of Deltex Medical Group, assuming nothing else is changed. The correlation between historical values of Deltex Medical's Net Income From Continuing Ops and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Deltex Medical Group are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Net Income From Continuing Ops i.e., Deltex Medical's Net Income From Continuing Ops and Ebitda go up and down completely randomly.

Correlation Coefficient

0.98

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Net Income From Continuing Ops

Ebitda

Most indicators from Deltex Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Deltex Medical Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Deltex Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Deltex Medical's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is expected to grow at the current pace this year, whereas Issuance Of Capital Stock is likely to drop slightly above 1.1 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	173K	199K	230K	116.1K
Depreciation And Amortization	114K	128K	133K	231.8K

Interest Expense Depreciation And Amortization

Deltex Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Net Receivables
Total Assets		0.78	0.66	0.6	0.9	0.72	-0.21	-0.61	0.3	0.63	-0.05	-0.11	0.63	0.09	-0.01	0.21	0.88	0.18	0.41	0.83	0.0	0.79	0.37	0.08	0.54	0.57
Short Long Term Debt Total	0.78		0.35	0.52	0.6	0.42	0.26	-0.53	0.48	0.26	0.03	-0.1	0.26	0.05	-0.01	0.34	0.68	0.29	0.59	0.76	0.25	0.59	0.48	0.08	0.65	0.52
Other Current Liab	0.66	0.35		0.84	0.44	0.8	-0.33	-0.17	0.26	0.47	-0.5	-0.44	0.47	-0.33	-0.43	-0.45	0.48	0.08	-0.14	0.73	-0.37	0.68	0.7	-0.36	0.34	0.62
Total Current Liabilities	0.6	0.52	0.84		0.23	0.67	0.02	-0.18	0.6	0.18	-0.57	-0.61	0.18	-0.44	-0.59	-0.42	0.45	0.36	0.11	0.88	-0.37	0.64	0.86	-0.45	0.53	0.71
Total Stockholder Equity	0.9	0.6	0.44	0.23		0.59	-0.41	-0.56	-0.01	0.75	0.19	0.12	0.75	0.29	0.23	0.38	0.82	0.0	0.29	0.5	0.15	0.63	0.05	0.27	0.28	0.3
Property Plant And Equipment Net	0.72	0.42	0.8	0.67	0.59		-0.49	-0.05	0.36	0.71	-0.49	-0.37	0.71	-0.39	-0.43	-0.4	0.6	0.33	-0.03	0.65	-0.37	0.87	0.6	-0.42	0.43	0.67
Net Debt	-0.21	0.26	-0.33	0.02	-0.41	-0.49		-0.38	0.22	-0.84	0.24	0.18	-0.84	0.31	0.27	0.17	-0.3	0.16	0.45	0.13	0.34	-0.43	0.04	0.33	0.15	-0.17
Retained Earnings	-0.61	-0.53	-0.17	-0.18	-0.56	-0.05	-0.38		0.07	0.03	-0.48	-0.33	0.03	-0.74	-0.6	-0.43	-0.48	0.08	-0.55	-0.53	-0.43	-0.09	0.11	-0.72	-0.18	0.07
Accounts Payable	0.3	0.48	0.26	0.6	-0.01	0.36	0.22	0.07		-0.01	-0.42	-0.34	-0.01	-0.57	-0.54	-0.11	0.39	0.72	0.58	0.56	-0.39	0.58	0.63	-0.56	0.85	0.73
Cash	0.63	0.26	0.47	0.18	0.75	0.71	-0.84	0.03	-0.01		-0.14	-0.08	1.0	-0.19	-0.15	0.0	0.67	-0.03	-0.1	0.26	-0.12	0.73	0.15	-0.2	0.22	0.39
Non Current Assets Total	-0.05	0.03	-0.5	-0.57	0.19	-0.49	0.24	-0.48	-0.42	-0.14		0.63	-0.14	0.85	0.85	0.59	0.08	-0.24	0.29	-0.31	0.79	-0.48	-0.55	0.87	-0.33	-0.69
Non Currrent Assets Other	-0.11	-0.1	-0.44	-0.61	0.12	-0.37	0.18	-0.33	-0.34	-0.08	0.63		-0.08	0.59	0.87	0.32	-0.15	-0.11	0.17	-0.37	0.58	-0.34	-0.54	0.61	-0.09	-0.56
Cash And Short Term Investments	0.63	0.26	0.47	0.18	0.75	0.71	-0.84	0.03	-0.01	1.0	-0.14	-0.08		-0.19	-0.15	0.0	0.67	-0.03	-0.1	0.26	-0.12	0.73	0.15	-0.2	0.22	0.39
Common Stock Total Equity	0.09	0.05	-0.33	-0.44	0.29	-0.39	0.31	-0.74	-0.57	-0.19	0.85	0.59	-0.19		0.9	0.54	0.05	-0.37	0.26	-0.14	0.69	-0.46	-0.6	0.99	-0.42	-0.66
Common Stock Shares Outstanding	-0.01	-0.01	-0.43	-0.59	0.23	-0.43	0.27	-0.6	-0.54	-0.15	0.85	0.87	-0.15	0.9		0.48	-0.06	-0.33	0.2	-0.28	0.75	-0.47	-0.62	0.92	-0.32	-0.7
Non Current Liabilities Total	0.21	0.34	-0.45	-0.42	0.38	-0.4	0.17	-0.43	-0.11	0.0	0.59	0.32	0.0	0.54	0.48		0.33	-0.14	0.6	-0.06	0.35	-0.09	-0.57	0.54	0.06	-0.12
Inventory	0.88	0.68	0.48	0.45	0.82	0.6	-0.3	-0.48	0.39	0.67	0.08	-0.15	0.67	0.05	-0.06	0.33		0.23	0.55	0.68	-0.02	0.79	0.26	0.04	0.58	0.56
Other Current Assets	0.18	0.29	0.08	0.36	0.0	0.33	0.16	0.08	0.72	-0.03	-0.24	-0.11	-0.03	-0.37	-0.33	-0.14	0.23		0.45	0.32	-0.24	0.35	0.43	-0.36	0.53	0.36
Other Stockholder Equity	0.41	0.59	-0.14	0.11	0.29	-0.03	0.45	-0.55	0.58	-0.1	0.29	0.17	-0.1	0.26	0.2	0.6	0.55	0.45		0.43	0.13	0.27	-0.03	0.25	0.62	0.28
Total Liab	0.83	0.76	0.73	0.88	0.5	0.65	0.13	-0.53	0.56	0.26	-0.31	-0.37	0.26	-0.14	-0.28	-0.06	0.68	0.32	0.43		-0.17	0.72	0.65	-0.15	0.67	0.71
Property Plant And Equipment Gross	0.0	0.25	-0.37	-0.37	0.15	-0.37	0.34	-0.43	-0.39	-0.12	0.79	0.58	-0.12	0.69	0.75	0.35	-0.02	-0.24	0.13	-0.17		-0.42	-0.21	0.74	-0.27	-0.64
Total Current Assets	0.79	0.59	0.68	0.64	0.63	0.87	-0.43	-0.09	0.58	0.73	-0.48	-0.34	0.73	-0.46	-0.47	-0.09	0.79	0.35	0.27	0.72	-0.42		0.54	-0.48	0.75	0.88
Short Term Debt	0.37	0.48	0.7	0.86	0.05	0.6	0.04	0.11	0.63	0.15	-0.55	-0.54	0.15	-0.6	-0.62	-0.57	0.26	0.43	-0.03	0.65	-0.21	0.54		-0.57	0.51	0.6
Common Stock	0.08	0.08	-0.36	-0.45	0.27	-0.42	0.33	-0.72	-0.56	-0.2	0.87	0.61	-0.2	0.99	0.92	0.54	0.04	-0.36	0.25	-0.15	0.74	-0.48	-0.57		-0.41	-0.68
Other Liab	0.54	0.65	0.34	0.53	0.28	0.43	0.15	-0.18	0.85	0.22	-0.33	-0.09	0.22	-0.42	-0.32	0.06	0.58	0.53	0.62	0.67	-0.27	0.75	0.51	-0.41		0.8
Net Receivables	0.57	0.52	0.62	0.71	0.3	0.67	-0.17	0.07	0.73	0.39	-0.69	-0.56	0.39	-0.66	-0.7	-0.12	0.56	0.36	0.28	0.71	-0.64	0.88	0.6	-0.68	0.8

Click cells to compare fundamentals

Deltex Medical Account Relationship Matchups

Deltex Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.5M	5.5M	5.4M	6.2M	5.9M	5.5M
Short Long Term Debt Total	1.6M	1.5M	2.0M	2.2M	1.9M	1.7M
Other Current Liab	1.7M	975K	908K	784K	530K	503.5K
Total Current Liabilities	2.4M	1.6M	2.2M	2.6M	934K	887.3K
Total Stockholder Equity	2.8M	2.8M	2.0M	2.3M	3.3M	2.5M
Property Plant And Equipment Net	395K	305K	264K	269K	198K	347.6K
Net Debt	704K	614K	1.6M	1.8M	1.2M	1.3M
Retained Earnings	(53.8M)	(54.6M)	(55.6M)	(56.6M)	(57.8M)	(60.7M)
Accounts Payable	381K	201K	298K	507K	173K	164.4K
Cash	908K	853K	413K	471K	705K	920.5K
Non Current Assets Total	3.2M	3.0M	3.6M	4.2M	4.2M	4.4M
Non Currrent Assets Other	(461K)	(371K)	(330K)	(335K)	3.9M	4.1M
Cash And Short Term Investments	908K	853K	413K	471K	705K	920.5K
Common Stock Total Equity	3.1M	4.9M	5.2M	5.8M	6.6M	7.0M
Common Stock Shares Outstanding	509.7M	526.4M	580.7M	685.5M	1.2B	1.2B
Liabilities And Stockholders Equity	6.5M	5.5M	5.4M	6.2M	5.9M	5.5M
Non Current Liabilities Total	1.5M	1.3M	1.3M	1.3M	1.9M	977.1K
Inventory	915K	895K	796K	821K	716K	782.2K
Other Current Assets	49K	198K	175K	227K	171K	162.5K
Other Stockholder Equity	33.2M	33.4M	33.5M	33.7M	35.7M	34.5M
Total Liab	3.8M	2.9M	3.5M	3.9M	2.8M	3.1M
Property Plant And Equipment Gross	395K	305K	2.7M	2.4M	2.1M	2.2M
Total Current Assets	3.3M	2.5M	1.8M	2.0M	1.8M	2.7M
Accumulated Other Comprehensive Income	18.1M	18.2M	18.3M	18.3M	18.2M	19.1M
Short Term Debt	220K	200K	748K	987K	137K	130.2K
Common Stock	5.2M	5.8M	5.8M	7.0M	7.2M	7.6M
Other Liab	62K	51K	57K	64K	73.6K	92.9K
Net Receivables	1.4M	737K	455K	456K	177K	168.2K
Property Plant Equipment	395K	305K	264K	269K	309.4K	354.3K
Long Term Debt	1.0M	1.1M	993K	1.1M	1.7M	996.9K
Current Deferred Revenue	53K	58K	57K	39K	468K	491.4K
Intangible Assets	2.7M	2.6M	3.1M	3.8M	3.9M	4.1M
Other Assets	2.7M	2.6M	1.0	3.9M	4.4M	4.7M
Net Tangible Assets	2.7M	2.7M	2.0M	2.3M	2.1M	2.1M
Deferred Long Term Liab	2.6M	2.5M	3.1M	3.7M	4.3M	2.6M
Short Long Term Debt	188K	159K	702K	935K	79K	75.1K
Capital Lease Obligations	352K	315K	274K	229K	177K	194.8K
Net Invested Capital	4.1M	3.9M	3.8M	4.4M	5.0M	4.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Deltex Stock Analysis

When running Deltex Medical's price analysis, check to measure Deltex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deltex Medical is operating at the current time. Most of Deltex Medical's value examination focuses on studying past and present price action to predict the probability of Deltex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deltex Medical's price. Additionally, you may evaluate how the addition of Deltex Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Deltex Net Income From Continuing Ops vs Ebitda Analysis

Net Income From Continuing Ops vs Ebitda

Net Income From Continuing Ops vs Ebitda Correlation Analysis

Correlation Coefficient

Net Income From Continuing Ops

Ebitda

Deltex Medical fundamental ratios Correlations

Deltex Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Deltex Medical fundamental ratios Accounts

Also Currently Popular

Additional Tools for Deltex Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 0.99	Common Stock Total Equity
Common Stock	+ 0.92	Common Stock Shares Outstanding
Total Stockholder Equity	+ 0.9	Total Assets
Common Stock Shares Outstanding	+ 0.9	Common Stock Total Equity
Inventory	+ 0.88	Total Assets

Cash And Short Term Investments	- 0.84	Net Debt
Cash	- 0.84	Net Debt
Common Stock Total Equity	- 0.74	Retained Earnings
Common Stock	- 0.72	Retained Earnings
Net Receivables	- 0.7	Common Stock Shares Outstanding
Net Receivables	- 0.69	Non Current Assets Total